← All Mutual Funds

DEUTSCHE DWS SECURITIES TRUST

CIK: 0000088048 Equity
Report date: 2026-04-27
AUM $259M
Expense Ratio
Category Equity
State
Fiscal Year End
Inception Date
Manager
Latest Filing 2026-04-27

About this Fund

DEUTSCHE DWS SECURITIES TRUST is a renowned mutual fund company that specializes in providing a wide range of investment solutions to cater to the diverse needs of its clients, leveraging its expertise in asset management to help investors achieve their financial goals. As a trusted name in the industry, the company offers a broad spectrum of mutual funds, including equity, debt, hybrid, and money market funds, each designed to provide a unique investment strategy and risk profile. Whether investors are seeking long-term growth, regular income, or a combination of both, DEUTSCHE DWS SECURITIES TRUST has a portfolio of funds that can help them navigate the complexities of the market and make informed investment decisions. The company's focus on wealth management is evident in its commitment to providing investors with a range of options to suit their individual financial objectives, risk tolerance, and investment horizon, making it an ideal partner for those looking to create a well-diversified investment portfolio. For investors who prefer a disciplined and systematic approach to investing, DEUTSCHE DWS SECURITIES TRUST offers a systematic investment plan, or SIP, that enables them to invest a fixed amount of money at regular intervals, regardless of the market's performance, helping to reduce timing risks and avoid emotional decision-making. The company's investment philosophy is built around a rigorous research process, a strong emphasis on risk management, and a long-term perspective, which has earned it the trust of investors who value stability, consistency, and transparency in their investment experience. With a strong track record of delivering superior investment performance and a commitment to putting its clients' interests first, DEUTSCHE DWS SECURITIES TRUST has established itself as a leader in the mutual fund industry, known for its expertise in asset management, its extensive range of investment products, and its dedication to helping investors achieve their financial aspirations. By combining cutting-edge investment strategies with a deep understanding of the markets and a passion for delivering exceptional client service, DEUTSCHE DWS SECURITIES TRUST continues to be the preferred choice of investors seeking a reliable and trusted partner to manage their investments and secure their financial future. The company's investment approach is centered on a thorough understanding of the markets, a keen sense of risk management, and a relentless pursuit of excellence in every aspect of its operations, from research and portfolio construction to trade execution and customer support. This commitment to excellence has enabled DEUTSCHE DWS SECURITIES TRUST to build a loyal client base and establish long-term relationships with its investors, who appreciate the company's transparency, integrity, and unwavering dedication to their financial well-being. As a mutual fund company that is deeply invested in the success of its clients, DEUTSCHE DWS SECURITIES TRUST is constantly seeking to innovate and improve its investment products and services, staying ahead of the curve in terms of market trends, regulatory requirements, and investor expectations. By doing so, the company aims to maintain its position as a trusted leader in the mutual fund industry, a reputation that is built on its unshakeable commitment to delivering outstanding investment performance, exceptional client service, and unparalleled value to its investors.

Holdings

From latest SEC N-PORT filing · US-listed stocks only

38 positions
# Security Name CUSIP Asset Type Weight % Value ($M) Quantity
1 ALNY Alnylam Pharmaceuticals Inc Since 2026-05-10 02043Q107 Equity (Common)
0.90%
$2.33 7,001
2 ABBV AbbVie Inc Since 2026-05-10 00287Y109 Equity (Common)
4.68%
$12.11 52,180
3 TMO Thermo Fisher Scientific Inc Since 2026-05-10 883556102 Equity (Common)
3.28%
$8.49 16,298
4 A Agilent Technologies Inc Since 2026-05-10 00846U101 Equity (Common)
0.93%
$2.40 19,806
5 BMRN BioMarin Pharmaceutical Inc Since 2026-05-10 09061G101 Equity (Common)
0.35%
$0.92 14,842
6 AZN AstraZeneca PLC Since 2026-05-10 Equity (Common)
3.82%
$9.90 47,473
7 MDT Medtronic PLC Since 2026-05-10 Equity (Common)
1.83%
$4.74 48,488
8 ZTS Zoetis Inc Since 2026-05-10 98978V103 Equity (Common)
1.10%
$2.84 21,656
9 RMD ResMed Inc Since 2026-05-10 761152107 Equity (Common)
0.93%
$2.40 9,347
10 APLS Apellis Pharmaceuticals Inc Since 2026-05-10 03753U106 Equity (Common)
0.03%
$0.07 3,200
11 BIIB Biogen Inc Since 2026-05-10 09062X103 Equity (Common)
0.83%
$2.14 11,150
12 EYPT EyePoint Inc Since 2026-05-10 30233G209 Equity (Common)
0.15%
$0.39 21,900
13 IQV IQVIA Holdings Inc Since 2026-05-10 46266C105 Equity (Common)
0.79%
$2.04 11,400
14 VEEV Veeva Systems Inc Since 2026-05-10 922475108 Equity (Common)
0.37%
$0.95 5,218
15 NVO Novo Nordisk A/S Since 2026-05-10 670100205 Equity (Common)
1.28%
$3.30 88,210
16 ILMN Illumina Inc Since 2026-05-10 452327109 Equity (Common)
0.24%
$0.63 4,691
17 GMED Globus Medical Inc Since 2026-05-10 379577208 Equity (Common)
0.30%
$0.77 8,100
18 ISRG Intuitive Surgical Inc Since 2026-05-10 46120E602 Equity (Common)
2.85%
$7.38 14,659
19 AMGN Amgen Inc Since 2026-05-10 031162100 Equity (Common)
2.97%
$7.68 19,793
20 LH Labcorp Holdings Inc Since 2026-05-10 504922105 Equity (Common)
0.39%
$1.01 3,490
21 ABT Abbott Laboratories Since 2026-05-10 002824100 Equity (Common)
2.91%
$7.54 64,801
22 PRVA Privia Health Group Inc Since 2026-05-10 74276R102 Equity (Common)
0.38%
$0.98 41,332
23 GEHC GE HealthCare Technologies Inc Since 2026-05-10 36266G107 Equity (Common)
0.63%
$1.64 19,500
24 DXCM Dexcom Inc Since 2026-05-10 252131107 Equity (Common)
0.70%
$1.81 24,708
25 PFE Pfizer Inc Since 2026-05-10 717081103 Equity (Common)
1.11%
$2.86 103,470
26 CAH Cardinal Health Inc Since 2026-05-10 14149Y108 Equity (Common)
1.50%
$3.87 16,900
27 COR Cencora Inc Since 2026-05-10 03073E105 Equity (Common)
1.55%
$4.02 10,814
28 RDNT RadNet Inc Since 2026-05-10 750491102 Equity (Common)
0.67%
$1.75 24,997
29 NTRA Natera Inc Since 2026-05-10 632307104 Equity (Common)
0.36%
$0.94 4,500
30 NBIX Neurocrine Biosciences Inc Since 2026-05-10 64125C109 Equity (Common)
0.59%
$1.53 11,537
31 HUM Humana Inc Since 2026-05-10 444859102 Equity (Common)
0.23%
$0.59 3,116
32 REGN Regeneron Pharmaceuticals Inc Since 2026-05-10 75886F107 Equity (Common)
1.78%
$4.60 5,885
33 NVS Novartis AG Since 2026-05-10 66987V109 Equity (Common)
2.91%
$7.54 44,700
34 MRK Merck & Co Inc Since 2026-05-10 58933Y105 Equity (Common)
4.53%
$11.73 94,719
35 WST West Pharmaceutical Services Inc Since 2026-05-10 955306105 Equity (Common)
0.49%
$1.28 5,015
36 IDXX IDEXX Laboratories Inc Since 2026-05-10 45168D104 Equity (Common)
0.78%
$2.03 3,089
37 BAX Baxter International Inc Since 2026-05-10 071813109 Equity (Common)
0.22%
$0.56 27,600
38 GILD Gilead Sciences Inc Since 2026-05-10 375558103 Equity (Common)
2.75%
$7.13 47,850
Frequently Asked Questions — DEUTSCHE DWS SECURITIES TRUST
What type of mutual fund is DEUTSCHE DWS SECURITIES TRUST?
DEUTSCHE DWS SECURITIES TRUST is a SEC-registered Equity fund, with $259M in assets under management. Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate. As of its latest SEC N-PORT filing, DEUTSCHE DWS SECURITIES TRUST holds 38 portfolio positions, all detailed in the holdings table on this page.
What are DEUTSCHE DWS SECURITIES TRUST's assets under management (AUM)?
DEUTSCHE DWS SECURITIES TRUST has $259M in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting. AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale. AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are DEUTSCHE DWS SECURITIES TRUST's top holdings?
According to DEUTSCHE DWS SECURITIES TRUST's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include Alnylam Pharmaceuticals Inc, AbbVie Inc, Thermo Fisher Scientific Inc , among others. The complete list of all 38 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above. Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is DEUTSCHE DWS SECURITIES TRUST's expense ratio?
Expense ratio data for DEUTSCHE DWS SECURITIES TRUST is not currently available in StockSifting's database. The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors. For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find DEUTSCHE DWS SECURITIES TRUST's SEC filings?
DEUTSCHE DWS SECURITIES TRUST is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0000088048. You can access all of DEUTSCHE DWS SECURITIES TRUST's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on SEC EDGAR (CIK: 0000088048). N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is DEUTSCHE DWS SECURITIES TRUST's holdings data on StockSifting?
Holdings data for DEUTSCHE DWS SECURITIES TRUST on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing. Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions. The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released. For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.